Serotonin transporter gene may be involved in short-term risk of subsequent suicide attempts

Biological Psychiatry

Volumn 55, Issue 1, 2004, Pages 46-51

  Courtet, Philippe ^a,b   Picot, Marie Christine ^a   Bellivier, Frank ^d,e   Torres, Stephane ^b,c   Jollant, Fabrice ^a,b   Michelon, Cécile ^a   Castelnau, Didier ^a   Astruc, Bernard ^a   Buresi, Catherine ^f   Malafosse, Alain ^b,f  

^a Montpellier 1 University   (France)

^b LAPEYRONIE HOSPITAL   (France)

^c HÔPITAL ARNAUD DE VILLENEUVE   (France)

^d FACULTÉ DE MÉDECINE   (France)

^e HENRI MONDOR HOSPITAL   (France)

^f GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Association study; Impulsivity; Polymorphism; Repetition; Serotonin transporter; Suicidal behavior; Tryptophan hydroxylase

Indexed keywords

SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SUICIDE ATTEMPT;

EID: 9144240628     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2003.07.004     Document Type: Article

References (49)

1. Abbar M., Courtet P., Bellivier F., Leboyer M., Boulenger J.P., Castelhau D., et al. Suicide attempts and the tryptophan hydroxylase gene. Mol Psychiatry. 6:2001;268-273.
2. Appleby L., Shaw J., Amos T., McDonnell R., Harris C., McCann K., et al. Suicide within 12 months of contact with mental health services. National clinical survey. BMJ. 318:1999;1235-1239.
3. Armitage P., Berry G. Statistical Methods in Medical Research. 1987;Blackwell Scientific Publications, Oxford, England.
4. Asberg M., Träskman L., Thoren P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry. 33:1976;1193-1197. 371-407.
5. Bayle F.J., Bourdel M.C., Caci H., Gorwood P., Chignon J.M., Ades J., et al. Factor analysis of French translation of the Barratt impulsivity scale (BIS-10). Can J Psychiatry. 45:2000;156-165.
6. Beck A.T., Beck R., Kovacs M. Classification of suicidal behaviors I. Quantifying intent and medical lethality . Am J Psychiatry. 132:1975;285-287.
7. Beck A.T., Steer R.A. Clinical predictors of eventual suicide A 5- to 10-year prospective study of suicide attempters . J Affect Disord. 17:1989;203-209.
8. Bellivier F, Chaste P, Malafosse A (in press): Association between the TPH gene A218 polymorphism and suicidal behavior: A meta-analysis. Am J Med Genet. Published online March 14, 2003.
9. Bellivier F., Roy I., Leboyer M. Serotonin transporter gene polymorphisms and affective disorder-related phenotypes. Curr Opin Psychiatry. 15:2002;49-58.
10. Bennett A.J., Lesch K.P., Heils A., Long J.C., Lorenz J.G., Shoaf S.E., et al. Early experience and serotonin transporter gene variation interact to influence primate CNS function. Mol Psychiatry. 7:2002;118-122.
11. Bondy B., Erfurth A., Jonge S., Kruger M., Meyer H. Possible association of the short allele of the serotonin transporter promoter gene polymorphism (5-HTTLPR) with violent suicide. Mol Psychiatry. 5:2000;193-195.
12. Brauns M.L., Berzewski H. Follow-up study of patients with attempted suicide. Int J Soc Psychiatry. 34:1988;285-291.
13. Brent D.A., Bridge J., Johnson B.A., Connolly J. Suicidal behavior runs in families. A controlled family study of adolescent suicide victims. Arch Gen Psychiatry. 53:1996;1145-1152.
14. Brodsky B.S., Malone K.M., Ellis S.P., Dulit R.A., Mann J.J. Characteristics of borderline personality disorder associated with suicidal behavior. Am J Psychiatry. 154:1997;1715-1719.
15. Coccaro E.F., Bergeman C.S., Kavoussi R.J., Seroczynski A.D. Heritability of aggression and irritability A twin study of the Buss-Durkee aggression scales in adult male subjects . Biol Psychiatry. 41:1997;273-284.
16. Coccaro E.F., Silverman J.M., Klar H.M., Horvath T.B., Siever L.J. Familial correlates of reduced central serotonergic system function in patients with personality disorders. Arch Gen Psychiatry. 51:1994;318-324.
17. Courtet P., Baud P., Abbar M., Boulenger J.P., Castelnau D., Mouthon D., et al. Association between violent suicidal behavior and the low activity allele of the serotonin transporter gene. Mol Psychiatry. 6:2001;338-341.
18. Courtet P., Buresi C., Abbar M., Baud P., Boulenger J.P., Castelnau D., et al. No association between non-violent suicidal behavior and the serotonin transporter promoter polymorphism. Am J Med Genet. 116:(suppl 1):2003;72-76.
19. Hariri A.R., Mattay V.S., Tessitore A., Kolachana B., Fera F., Goldman D., et al. Serotonin transporter genetic variation and the response of the human amygdala. Science. 297:2002;400-403.
20. Hawton K., Arensman E., Townsend E., Bremner S., Feldman E., Goldney R., et al. Deliberate self harm Systematic review of efficacy of psychosocial and pharmacological treatments in preventing repetition . BMJ. 317:1998;441-447.
21. Hawton K., Bancroft J., Catalan J., Kingston B., Stedeford A., Welch N. Domiciliary and out-patient treatment of self-poisoning patients by medical and non-medical staff. Psychol Med. 11:1981;169-177.
22. Hosmer D.W., Lemeshow S. Applied Logistic Regression. 1989;John Wiley and Sons, Inc, New York.
23. Isacsson G., Rich C.L. Management of patients who deliberately harm themselves. BMJ. 322:2001;213-215. 431.
24. Johnsson-Fridell E., Ojehagen A., Traskman-Bendz L. A 5-year follow-up study of suicide attempts. Acta Psychiatr Scand. 93:1996;151-157.
25. Leon A.C., Friedman R.A., Sweeney J.A., Brown R.P., Mann J.J. Statistical issues in the identification of risk factors for suicidal behavior The application of survival analysis . Psychiatry Res. 31:1990;99-108.
26. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 274:1996;1527-1531.
27. Malone K.M., Haas G.L., Sweeney J.A., Mann J.J. Major depression and the risk of attempted suicide. J Affect Disord. 34:1995;173-185.
28. Mann J.J. The neurobiology of suicide. Nat Med. 4:1998;25-30.
29. Mann J.J., Waternaux C., Haas G.L., Malone K.M. Toward a clinical model of suicidal behavior in psychiatric patients. Am J Psychiatry. 156:1999;181-189.
30. Marusic A., Farmer A. Toward a new classification of risk factors for suicide behavior. Crisis. 22:2001;43-46.
31. Nordström P.M., Samuelsson M., Asberg M., Traskman-Bendz L., Aberg-Wistedt A., Nordin C., et al. CSF 5-HIAA predicts suicide risk after attempted suicide. Suicide Life Threat Behav. 24:1994;1-9.
32. Oquendo M.A., Placidi G.P., Malone K.M., Campbell C., Keilp J., Brodsky B., et al. Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression. Arch Gen Psychiatry. 60:2003;14-22.
33. Owens D., Horrocks J., House A. Fatal and non-fatal repetition of self-harm. Systematic review. Br J Psychiatry. 181:2002;193-199.
34. Paris J. Social Factors in the Personality Disorders. A Biopsychosocial Approach to Etiology and Treatment. 1996;Cambridge University Press, Cambridge, England.
35. Placidi G.P., Oquendo M.A., Malone K.M., Huang Y.Y., Ellis S.P., Mann J.J. Aggressivity, suicide attempts, and depression Relationship to cerebrospinal fluid monoamine metabolite levels . Biol Psychiatry. 50:2001;783-791.
36. Reist C., Mazzanti C., Vu R., Tran D., Goldman D. Serotonin transporter promoter polymorphism is associated with attenuated prolactin response to fenfluramine. Am J Med Genet. 105:2001;363-368.
37. Rissmiller D.J., Steer R., Ranieri W.F., Rissmiller F., Hogate P. Factors complicating cost containment in the treatment of suicidal patients. Hosp Community Psychiatry. 45:1994;782-788.
38. Rossi A., Amaddeo F., Bisoffi G., Ruggeri M., Thornicroft G., Tansella M. Dropping out of care Inappropriate terminations of contact with community-based psychiatric services . Br J Psychiatry. 181:2002;331-338.
39. Roy A. Suicidal behavior in depression Relationship to platelet serotonin transporter . Neuropsychobiology. 39:1999;71-75.
40. Roy A., De Jong J., Linnoila M. Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5-year follow-up study. Arch Gen Psychiatry. 46:1989;609-612.
41. Rygnestad T. A prospective 5-year follow-up study of self-poisoned patients. Acta Psychiatr Scand. 77:1988;328-331.
42. SAS/STAT Users' Guide, Version 6, 4th ed, vol. 2. 1989;SAS Institute, Inc, Cary, NC.
43. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.). The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 59:(suppl 20):1998;22-33.
44. Traskman L., Asberg M., Bertilsson L., Sjostrand L. Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry. 38:1981;631-636.
45. van der Sande R., van Rooijen L., Buskens E., Allart E., Hawton K., van der Graaf Y., et al. Intensive in-patient and community intervention versus routine care after attempted suicide. A randomised controlled intervention study. Br J Psychiatry. 171:1997;35-41.
46. Van Heeringen C., Jannes S., Buylaert W., Henderick H., De Bacquer D., Van Remoortel J. The management of non-compliance with referral to out-patient after-care among attempted suicide patients A controlled intervention study . Psychol Med. 25:1995;963-970.
47. Verkes R.J., Van der Mast R.C., Hengeveld M.W., Tuyl J.P., Zwinderman A.H., Van Kempen G.M. Reduction by paroxetine of suicidal behavior in patients with repeated suicide attempts but not major depression. Am J Psychiatry. 155:1998;543-547.
48. Walther D.J., Peter J.U., Bashammakh S., Hortnagl H., Volts M., Fink H., et al. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science. 299:2003;76.
49. World Health Organization (1999): Health 21: The Health for all Framework for the WHO European Region. European Health for All Series No 6. Copenhagen, Denmark: World Health Organization, Regional Office for Europe.